Compare Hetzer Medical Indonesia Tbk. (MEDS) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hetzer Medical Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Hetzer Medical Indonesia Tbk. trades at Rp72 (market cap 114.06B, 23.06M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is the larger of the two by market cap, and Hetzer Medical Indonesia Tbk. is more actively traded (23.06M versus 62.5K). Which is the better fit depends on your goals.
| MEDS | OBAT | |
|---|---|---|
Market Cap | 114.06B | 164.65B |
Volume | 23.06M | 62.5K |
Lot | 230.55K | 625 |
Turnover | 1.68B | 15.03M |
Average Price | 72.75 | 240.55 |
Value | 1.68B | 15.03M |
Indicative Equilibrium Price | 72 | 238 |
Indicative Equilibrium Volume | 1.56K | 100 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hetzer Medical Indonesia Tbk.
PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.
Read more on MEDS →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
